Qube Research & Technologies (QRT)
ATYR

Qube Research & Technologies (QRT)’s aTyr Pharma ATYR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-414,592
Closed -$1.25M – 4062
2025
Q1 		$1.25M Sell
414,592
-15,432
-4% -$56.3K ﹤0.01% 2171
2024
Q4 		$1.56M Buy
430,024
+290,869
+209% +$881K ﹤0.01% 1983
2024
Q3 		$245K Buy
139,155
+138,967
+73,919% +$253K ﹤0.01% 2509
2024
Q2 		$294 Sell
188
-9,456
-98% -$16.5K ﹤0.01% 3361
2024
Q1 		$18.8K Buy
9,644
+9,456
+5,030% +$16.5K ﹤0.01% 3704
2023
Q4 		$265 Hold
188
– – ﹤0.01% 3960
2023
Q3 		$297 Buy
+188
New +$348 ﹤0.01% 3716
2022
Q1 		– Sell
-11,665
Closed -$87K – 3110
2021
Q4 		$87K Buy
+11,665
New +$97.3K ﹤0.01% 2169

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ATYR Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of aTyr Pharma (ATYR) in Q2 2025, closing a stake of 414,592 shares — an estimated $1.25M sold.

Qube Research & Technologies (QRT) first reported a position in ATYR in Q4 2021 and held it in 8 quarters. The position peaked at $1.56M in Q4 2024. 110 funds tracked by Wall St. Rank hold ATYR as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining aTyr Pharma position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 414,592 aTyr Pharma shares in Q2 2025, an estimated $1.25M.
  • Qube Research & Technologies (QRT) first reported a position in aTyr Pharma in Q4 2021 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s aTyr Pharma position peaked at $1.56M in Q4 2024.
  • 110 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.